WATCH LIVE

Donald Trump makes appearance on the convention floor during the first night of the RNC

Merck, Moderna detail potential skin cancer vaccine progress

The drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in recurrence-free survival time in patients with phase three or four melanoma who had tumors removed in surgery.

Associated Press

Dec 13, 2022, 2:44 PM

Updated 580 days ago

Share:

Merck, Moderna detail potential skin cancer vaccine progress
Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer.
The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in a small study of patients who had the cancer surgically removed.
The drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in survival before the cancer returned in patients with advanced melanoma.
“We are very excited, we are moving very quickly with Merck onto phase 3 for this study,” Moderna CEO Stephane Bancel told CNBC Tuesday morning.
Phase 3 is generally the largest and most expensive stage of clinical research before regulators review a potential drug for approval.
Moderna developed one of the most popular vaccines used to protect patients against COVID-19, and the drugmaker brought in more than $3 billion from its Spikevax in this year's third quarter.
But vaccine use has slowed, and Moderna depends on Spikevax for nearly all its revenue.
Like Spikevax, the potential skin cancer vaccine uses mRNA technology. It trains a patient’s immune system to recognize and respond specifically to mutations in the DNA of the patient’s tumor.
In a mid-stage clinical trial involving 157 patients, researchers compared the vaccine-Keytruda combination with Keytruda alone.
Keytruda, Merck’s top seller, primes the body’s immune system to detect and fight tumor cells. Regulators have approved it to treat several types of cancer.
The patient group that took the potential vaccine and Keytruda saw a 44% reduction in the risk of death or the cancer returning, the companies said.
The treatments continued for about a year in both groups unless the disease came back or side effects became too severe.
Merck and Moderna expect to start a phase 3 study next year, and the companies say they intend to expand their approach to other tumor types.
Merck and Moderna established an agreement to work together in 2016, and the companies plan to share costs and profits in their collaboration. Merck also paid Moderna $250 million.
Shares of Cambridge, Massachusetts-based Moderna Inc. soared 23% to top $200 in midday trading while broader indexes climbed. Kenilworth, New Jersey-based Merck & Co. climbed less than 1%.


More from News 12
2:22
Prosecutor: Manchester murder investigation leads to discovery bags of body parts

Prosecutor: Manchester murder investigation leads to discovery bags of body parts

2:41
HEAT ALERT: Excessive heat warning extended through Wednesday as temps rise

HEAT ALERT: Excessive heat warning extended through Wednesday as temps rise

7:10
Trump picks Sen. JD Vance of Ohio, a once-fierce critic turned loyal ally, as his GOP running mate

Trump picks Sen. JD Vance of Ohio, a once-fierce critic turned loyal ally, as his GOP running mate

2:23
NJ American Water issues mandatory water restrictions for parts of Ocean, Monmouth counties

NJ American Water issues mandatory water restrictions for parts of Ocean, Monmouth counties

Authorities identify victims killed in weekend house fire in West Orange

Authorities identify victims killed in weekend house fire in West Orange

1:33
‘People need heat relief.’ Paterson opens cooling centers as temps rise around NJ

‘People need heat relief.’ Paterson opens cooling centers as temps rise around NJ

0:24
Spokesperson: Rep. Bill Pascrell checks into hospital for fever

Spokesperson: Rep. Bill Pascrell checks into hospital for fever

2:55
Jury finishes 2nd day of deliberations without a verdict at Sen. Bob Menendez's bribery trial

Jury finishes 2nd day of deliberations without a verdict at Sen. Bob Menendez's bribery trial

0:24
Jersey Proud: Jersey City police officers promoted during Monday ceremony

Jersey Proud: Jersey City police officers promoted during Monday ceremony

1:34
Vacant building fire in Plainfield causes roof collapse; investigation underway

Vacant building fire in Plainfield causes roof collapse; investigation underway

1:18
Going for gold: A look at some New Jersey athletes heading to the Paris Olympic Games

Going for gold: A look at some New Jersey athletes heading to the Paris Olympic Games

0:28
Mays Landing man pleads guilty to murdering his mother

Mays Landing man pleads guilty to murdering his mother

2:04
Route 15 temporary bridge in Jefferson opens earlier than expected

Route 15 temporary bridge in Jefferson opens earlier than expected

0:28
Woman jumps out of window in Franklin Township to avoid being struck by bullets

Woman jumps out of window in Franklin Township to avoid being struck by bullets

2:14
Don't be caught in the dark: Are you ready to power through hurricane season?

Don't be caught in the dark: Are you ready to power through hurricane season?

0:48
NJ Attorney General’s Office releases video of fatal South Brunswick motel standoff with NYC suspect

NJ Attorney General’s Office releases video of fatal South Brunswick motel standoff with NYC suspect

3:30
Trump heads to convention as authorities investigate motive, security in assassination attempt

Trump heads to convention as authorities investigate motive, security in assassination attempt

0:23
Newark official: 5 men stabbed in Ironbound neighborhood

Newark official: 5 men stabbed in Ironbound neighborhood

3:04
Made in New Jersey: For nearly 150 years, Serratelli Hat Company in Newark has served the hat industry

Made in New Jersey: For nearly 150 years, Serratelli Hat Company in Newark has served the hat industry

0:24
Fire officials: 2 people trapped inside car after hitting parked trucks at Cherry Hill rest stop

Fire officials: 2 people trapped inside car after hitting parked trucks at Cherry Hill rest stop